Current Trends in Hemoadsorption Therapy

Dear Colleagues,

This Special Issue of the Journal of Clinical Medicine focuses on current trends in hemoadsorption therapy.

It is a real pleasure to be the guest editor of this Special Issue of the Journal of Clinical Medicine. Extracorporeal blood purification techniques have gained recent attention in various fields of clinical medicine, and these new and innovative devices can be safely and easily integrated in various extracorporeal circuits (heart–lung machine, ECMO or dialysis) and were capable of removing low-molecular-weight substances from blood by adsorption. Hemoadsorption is currently being applied in various indications in cardiac surgery, nephrology, intensive-care medicine, anesthesiology, transplantation or gastroenterology.  Hemoadsorption has the ability to modulate the immune response by attenuating the so-called “cytokine storm” and therefore has significant potential in the treatment of COVID-19 patients.  Moreover, hemoadsorption can be effectively used in treating severe sepsis, hyperbilirubinemia, endocarditis or high-risk cardiac surgery patients.  Additionally, in drug removal, mainly antithrombotic drugs, such as Ticagrelor or NOACs, hemoadorption will be the future game-changer. 

Therefore, the present Special Issue aims to provide the readers with an update of the current use of hemoadsorption technologies in various fields of clinical medicine. 

Prof. Dr. Daniel Wendt
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.